SAN DIEGO, Dec. 14, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that it has garnered news coverage in national news publication U.S. News & World Report.
A December 4, 2018 article on the legalization of hemp and its effects on marijuana entitled "Legalization of Hemp Could Be First Step for Federal Marijuana Protections" features an interview with Medical Marijuana, Inc. CEO Dr. Stuart Titus.
"We're very pleased to be included in the national conversation about such a monumental bill in U.S. history," said Titus. "Hemp has over 50,000 known uses and we believe that this publication has done a fantastic job at showcasing this bill's expansive potential for cannabidiol (CBD) companies and farmers alike."
The article outlines how Congress, who is currently on the brink of passing the 2018 Farm Bill, may also be headed towards the federal legalization of marijuana. The piece also highlights hemp's many industrial applications as biofuel and construction materials, a skincare supplement, as well as a source of CBD hemp oil, which holds countless health and wellness benefits.
In the article, Dr. Titus is quoted saying, "The 2018 farm bill is going to be a total game-changer. This bill is the first step in convincing Congress to consider marijuana not as a scary drug but as a relatively low-risk recreational intoxicant and a therapeutic agent."
U.S. News & World Report is a multi-platform media company that publishes news, opinion, consumer advice, and rankings, with a monthly audience of over 20 million unique visitors and 120 million page views. One of the fastest growing news and information brands, the publication brings its heritage of credible advice and guidance to a global online audience.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
SOURCE Medical Marijuana, Inc.